Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience.
- Publication date
- 1 January 2015
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'